ID   NEUA_MOUSE              Reviewed;         432 AA.
AC   Q99KK2; O88719; Q8C330; Q8K2G7;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 2.
DT   07-APR-2021, entry version 140.
DE   RecName: Full=N-acylneuraminate cytidylyltransferase;
DE            EC=2.7.7.43;
DE   AltName: Full=CMP-N-acetylneuraminic acid synthase;
DE            Short=CMP-NeuNAc synthase;
GN   Name=Cmas;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ENZYME ACTIVITY,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9689047; DOI=10.1073/pnas.95.16.9140;
RA   Muenster A.-K., Eckhardt M., Potvin B., Muehlenhoff M., Stanley P.,
RA   Gerardy-Schahn R.;
RT   "Mammalian cytidine 5-prime-monophosphate N-acetylneuraminic acid
RT   synthetase: a nuclear protein with evolutionarily conserved structural
RT   motifs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:9140-9145(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=C57BL/6J; TISSUE=Lung;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=FVB/N; TISSUE=Colon, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, ENZYME ACTIVITY, AND MUTAGENESIS OF LYS-198; ARG-199;
RP   PRO-200; ARG-201; ARG-202; GLN-203 AND ASP-204.
RX   PubMed=11893746; DOI=10.1074/jbc.m201093200;
RA   Muenster A.-K., Weinhold B., Gotza B., Muehlenhoff M., Frosch M.,
RA   Gerardy-Schahn R.;
RT   "Nuclear localization signal of murine CMP-Neu5Ac synthetase includes
RT   residues required for both nuclear targeting and enzymatic activity.";
RL   J. Biol. Chem. 277:19688-19696(2002).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Liver, and Pancreas;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-35 AND ARG-50, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, and Embryo;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 40-268 IN COMPLEX WITH CMP-NEUNAC,
RP   AND SUBUNIT.
RX   PubMed=14636592; DOI=10.1016/j.jmb.2003.09.080;
RA   Krapp S., Muenster-Kuehnel A.-K., Kaiser J.T., Huber R., Tiralongo J.,
RA   Gerardy-Schahn R., Jacob U.;
RT   "The crystal structure of murine CMP-5-N-acetylneuraminic acid
RT   synthetase.";
RL   J. Mol. Biol. 334:625-637(2003).
CC   -!- FUNCTION: Catalyzes the activation of N-acetylneuraminic acid (NeuNAc)
CC       to cytidine 5'-monophosphate N-acetylneuraminic acid (CMP-NeuNAc), a
CC       substrate required for the addition of sialic acid. Has some activity
CC       toward NeuNAc, N-glycolylneuraminic acid (Neu5Gc) or 2-keto-3-deoxy-D-
CC       glycero-D-galacto-nononic acid (KDN). {ECO:0000269|PubMed:9689047}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-acylneuraminate + CTP = a CMP-N-acyl-beta-neuraminate +
CC         diphosphate; Xref=Rhea:RHEA:11344, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:37563, ChEBI:CHEBI:60073, ChEBI:CHEBI:68671; EC=2.7.7.43;
CC         Evidence={ECO:0000269|PubMed:11893746, ECO:0000269|PubMed:9689047};
CC   -!- PATHWAY: Amino-sugar metabolism; N-acetylneuraminate metabolism.
CC   -!- SUBUNIT: Homotetramer; the active enzyme is formed by a dimer of
CC       dimers. {ECO:0000269|PubMed:14636592}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11893746,
CC       ECO:0000269|PubMed:9689047}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q99KK2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q99KK2-2; Sequence=VSP_012765;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain and heart, and at
CC       intermediate level muscle and liver. {ECO:0000269|PubMed:9689047}.
CC   -!- DOMAIN: The BC2 (basic cluster 2) motif is necessary and sufficient for
CC       the nuclear localization and contains the catalytic active site. The
CC       localization in the nucleus is however not required for the enzyme
CC       activity.
CC   -!- MISCELLANEOUS: [Isoform 2]: Inactive. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the CMP-NeuNAc synthase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ006215; CAA06915.1; -; mRNA.
DR   EMBL; AK087150; BAC39813.1; -; mRNA.
DR   EMBL; BC004606; AAH04606.1; -; mRNA.
DR   EMBL; BC031500; AAH31500.1; -; mRNA.
DR   EMBL; BC063776; AAH63776.1; -; mRNA.
DR   CCDS; CCDS20687.1; -. [Q99KK2-1]
DR   RefSeq; NP_034038.2; NM_009908.2.
DR   PDB; 1QWJ; X-ray; 2.80 A; A/B/C/D=40-268.
DR   PDB; 3EWI; X-ray; 1.90 A; A/B=267-432.
DR   PDBsum; 1QWJ; -.
DR   PDBsum; 3EWI; -.
DR   SMR; Q99KK2; -.
DR   BioGRID; 198764; 2.
DR   IntAct; Q99KK2; 2.
DR   MINT; Q99KK2; -.
DR   STRING; 10090.ENSMUSP00000032419; -.
DR   iPTMnet; Q99KK2; -.
DR   PhosphoSitePlus; Q99KK2; -.
DR   SwissPalm; Q99KK2; -.
DR   EPD; Q99KK2; -.
DR   PaxDb; Q99KK2; -.
DR   PeptideAtlas; Q99KK2; -.
DR   PRIDE; Q99KK2; -.
DR   ProteomicsDB; 252823; -. [Q99KK2-1]
DR   ProteomicsDB; 252824; -. [Q99KK2-2]
DR   GeneID; 12764; -.
DR   KEGG; mmu:12764; -.
DR   UCSC; uc009eps.2; mouse. [Q99KK2-1]
DR   CTD; 55907; -.
DR   MGI; MGI:1337124; Cmas.
DR   eggNOG; ENOG502QQH3; Eukaryota.
DR   InParanoid; Q99KK2; -.
DR   OrthoDB; 781897at2759; -.
DR   PhylomeDB; Q99KK2; -.
DR   TreeFam; TF324840; -.
DR   BioCyc; MetaCyc:MONOMER-14521; -.
DR   BRENDA; 2.7.7.43; 3474.
DR   Reactome; R-MMU-4085001; Sialic acid metabolism.
DR   SABIO-RK; Q99KK2; -.
DR   UniPathway; UPA00628; -.
DR   BioGRID-ORCS; 12764; 18 hits in 53 CRISPR screens.
DR   ChiTaRS; Cmas; mouse.
DR   EvolutionaryTrace; Q99KK2; -.
DR   PRO; PR:Q99KK2; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; Q99KK2; protein.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0008781; F:N-acylneuraminate cytidylyltransferase activity; ISO:MGI.
DR   GO; GO:0006055; P:CMP-N-acetylneuraminate biosynthetic process; ISO:MGI.
DR   GO; GO:0006054; P:N-acetylneuraminate metabolic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR003329; Cytidylyl_trans.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   Pfam; PF02348; CTP_transf_3; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Methylation;
KW   Nucleotidyltransferase; Nucleus; Reference proteome; Transferase.
FT   CHAIN           1..432
FT                   /note="N-acylneuraminate cytidylyltransferase"
FT                   /id="PRO_0000213200"
FT   MOTIF           15..31
FT                   /note="BC1 motif"
FT   MOTIF           198..204
FT                   /note="BC2 motif"
FT   MOTIF           267..274
FT                   /note="BC3 motif"
FT   ACT_SITE        199
FT   BINDING         50
FT                   /note="Substrate"
FT   BINDING         60
FT                   /note="Substrate"
FT   BINDING         109
FT                   /note="Substrate"
FT   BINDING         118
FT                   /note="Substrate"
FT   BINDING         120
FT                   /note="Substrate"
FT   BINDING         141
FT                   /note="Substrate"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFW8"
FT   MOD_RES         35
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         50
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   VAR_SEQ         1..232
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_012765"
FT   MUTAGEN         196
FT                   /note="P->A: Does not affect the nuclear localization."
FT   MUTAGEN         198
FT                   /note="K->A: Abolishes the nuclear localization but does
FT                   not affect the enzyme activity; when associated with A-
FT                   201."
FT                   /evidence="ECO:0000269|PubMed:11893746"
FT   MUTAGEN         199
FT                   /note="R->A: Abolishes both the nuclear localization and
FT                   the enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:11893746"
FT   MUTAGEN         200
FT                   /note="P->A: Does not affect neither the nuclear
FT                   localization nor the enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:11893746"
FT   MUTAGEN         201
FT                   /note="R->A: Abolishes the nuclear localization but does
FT                   not affect the enzyme activity; when associated with A-
FT                   198."
FT                   /evidence="ECO:0000269|PubMed:11893746"
FT   MUTAGEN         202
FT                   /note="R->A: Does not strongly affect the nuclear
FT                   localization but strongly affects the enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:11893746"
FT   MUTAGEN         203
FT                   /note="Q->A: Does not affect the nuclear localization but
FT                   affects the enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:11893746"
FT   MUTAGEN         204
FT                   /note="D->A: Does not affect the nuclear localization."
FT                   /evidence="ECO:0000269|PubMed:11893746"
FT   CONFLICT        9
FT                   /note="V -> A (in Ref. 3; AAH31500/AAH63776)"
FT                   /evidence="ECO:0000305"
FT   STRAND          43..48
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   STRAND          54..57
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   TURN            59..61
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   STRAND          62..64
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   HELIX           69..80
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   STRAND          84..91
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   HELIX           93..101
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   STRAND          105..108
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   HELIX           111..113
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   HELIX           120..128
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   STRAND          135..140
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   HELIX           149..160
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   STRAND          165..173
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   STRAND          191..195
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   TURN            202..204
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   STRAND          208..219
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   HELIX           220..224
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   STRAND          231..237
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   HELIX           240..242
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   HELIX           246..249
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   HELIX           252..262
FT                   /evidence="ECO:0007744|PDB:1QWJ"
FT   STRAND          275..279
FT                   /evidence="ECO:0007744|PDB:3EWI"
FT   HELIX           280..284
FT                   /evidence="ECO:0007744|PDB:3EWI"
FT   STRAND          298..302
FT                   /evidence="ECO:0007744|PDB:3EWI"
FT   HELIX           303..314
FT                   /evidence="ECO:0007744|PDB:3EWI"
FT   STRAND          318..322
FT                   /evidence="ECO:0007744|PDB:3EWI"
FT   HELIX           329..333
FT                   /evidence="ECO:0007744|PDB:3EWI"
FT   HELIX           348..358
FT                   /evidence="ECO:0007744|PDB:3EWI"
FT   HELIX           363..365
FT                   /evidence="ECO:0007744|PDB:3EWI"
FT   STRAND          366..369
FT                   /evidence="ECO:0007744|PDB:3EWI"
FT   HELIX           373..375
FT                   /evidence="ECO:0007744|PDB:3EWI"
FT   HELIX           376..381
FT                   /evidence="ECO:0007744|PDB:3EWI"
FT   STRAND          382..387
FT                   /evidence="ECO:0007744|PDB:3EWI"
FT   HELIX           393..396
FT                   /evidence="ECO:0007744|PDB:3EWI"
FT   STRAND          400..402
FT                   /evidence="ECO:0007744|PDB:3EWI"
FT   TURN            407..410
FT                   /evidence="ECO:0007744|PDB:3EWI"
FT   HELIX           411..426
FT                   /evidence="ECO:0007744|PDB:3EWI"
SQ   SEQUENCE   432 AA;  48058 MW;  BF7295535E7F6CE5 CRC64;
     MDALEKGAVT SGPAPRGRPS RGRPPKLQRS RGAGRGLEKP PHLAALVLAR GGSKGIPLKN
     IKRLAGVPLI GWVLRAALDA GVFQSVWVST DHDEIENVAK QFGAQVHRRS SETSKDSSTS
     LDAIVEFLNY HNEVDIVGNI QATSPCLHPT DLQKVAEMIR EEGYDSVFSV VRRHQFRWSE
     IQKGVREVTE PLNLNPAKRP RRQDWDGELY ENGSFYFAKR HLIEMGYLQG GKMAYYEMRA
     EHSVDIDVDI DWPIAEQRVL RFGYFGKEKL KEIKLLVCNI DGCLTNGHIY VSGDQKEIIS
     YDVKDAIGIS LLKKSGIEVR LISERACSKQ TLSALKLDCK TEVSVSDKLA TVDEWRKEMG
     LCWKEVAYLG NEVSDEECLK RVGLSAVPAD ACSGAQKAVG YICKCSGGRG AIREFAEHIF
     LLIEKVNNSC QK
//
